Aceste v. Stryker Corp.

2020 Ohio 4938
Ohio Court of Appeals·Decided October 16, 2020·No. L-19-1166·Published·Cited by 4 cases

Opinion

IN THE COURT OF APPEALS OF OHIO SIXTH APPELLATE DISTRICT

LUCAS COUNTY

Frank Aceste, et al. Court of Appeals No. L-19-1166 Appellants Trial Court No. CI0201504798 v. Stryker Corporation, et al. DECISION AND JUDGMENT Appellees Decided: October 16, 2020

*****

Karin L. Coble, for appellants.

Susan M. Audey and Tariq M. Naeem, for appellees, Stryker Corporation and Howmedica Osteonics Corp.

Paul C. Cosgrove and Joshua A. Klarfeld, and Georgia Hatzis, for appellee, Hammill Manufacturing Company.

*****

PIETRYKOWSKI, J.

{¶ 1} Appellants, Frank and Rhonda Aceste, appeal the judgment of the Lucas County Court of Common Pleas, dismissing with prejudice appellants’ claims against appellees, Stryker Corporation, Howmedica Osteonics Corporation, and Hammill Manufacturing Company. For the reasons that follow, we reverse.

I. Facts and Procedural Background

{¶ 2} The present matter was initiated on December 11, 2015, when appellants filed a complaint against appellees for compensatory damages related to medical problems and loss of consortium. The case was subsequently consolidated with another pending case involving a separate plaintiff. Relevant here, the claims were mediated over numerous sessions beginning in June 2016.

A. Trial Court Grants Appellees’ Motion to Enforce Settlement Agreement

{¶ 3} On April 10, 2017, appellees moved to enforce a settlement agreement that was purportedly reached during the mediation sessions. In their motion, appellees asserted that on September 30, 2016, counsel for appellants, Zoll & Kranz, LLC, sent correspondence to appellees confirming that appellants, among others, agreed to the settlement terms, including appellees’ payment of a sum of money to appellants, dismissal of the lawsuit with prejudice, release of all present and future claims against appellees, appellants’ responsibility for Medicare liens, and strict confidentiality and non- disparagement. Appellees also asserted that Zoll & Kranz indicated, in the September 30, 2016 correspondence, that as part of the informed consent process, appellants were provided with an explanatory form to review the terms of the settlement.

{¶ 4} The September 30, 2016 correspondence was not so specific regarding the settlement terms, however. The correspondence stated, in its entirety,

We have reached at least some conclusion with all remaining [redacted] clients.

As you know, we allocated the offer with the assistance of Special Master Judge Richard B. McQuade. Their responses can be broken into 3 categories:

Group A

[Redacted] people have accepted the allocated offer. [Redacted] of those have returned a signed form and we are still waiting on the remaining [redacted]. The total amount allocated to these [redacted] was [redacted].

Group B

[Redacted] people, [redacted] and [redacted] have accepted the allocated offer contingent on resolution of their liens such that they do not have to pay any subrogation. Both live in “made-whole” states where subrogation is not due until the client has been made whole and we have sent letters to both subrogation carriers demanding that they waive their liens. The total amount allocated to these [redacted] is [redacted].

Group C

[Redacted] people, [redacted] and [redacted], have rejected the allocated offer. The total amount allocated to these [redacted] was [redacted].

If you feel it would be helpful, we could provide Judge Welsh a copy of the Special Master’s letter to the clients with the spreadsheet showing each allocation and the bases for it. While the material is confidential and privileged, we hope that she will determine that Judge McQuade’s allocation was done fairly.

While we are still working to secure final signed acceptance as well as aggressively pursuing the lien resolution issue on behalf of [redacted]

clients, we have essentially reached what we feel is fairly (sic) optimistic point. We recognize there are a few contingent issues on behalf of our clients and we are mindful that is not precisely what Stryker was seeking. I welcome input on direction or next steps from this point.

{¶ 5} The next email, chronologically, that appellees attached to their motion to enforce the settlement agreement was a November 23, 2016 email wherein Zoll & Kranz sent to appellees their proposed Qualified Settlement Fund agreement (“QSF”) and proposed Medicare and Non-Medicare releases. On November 28, 2016, appellees replied with their proposed changes to the QSF and to the releases, and stated that if the documents were acceptable, then appellees would need a list of the individuals categorized into Medicare and Non-Medicare. On November 29, 2016, Zoll & Kranz approved the documents and sent to appellees a list of the Medicare status for all settled individuals for purposes of determining the correct release language. Appellants were included on this list. Appellees then requested a list of the actual settlement proceeds allocated to each person. In response, a second list identifying the settled individuals with their settlement allocations was sent to appellees on November 30, 2016. Again, appellants were included on the list.

{¶ 6} Based on the representations of Zoll & Kranz, appellees prepared the individualized “Confidential Settlement Agreement and Full Release,” which appellees claim memorialized the basic settlement terms to which the parties had already agreed. This release was sent to Zoll & Kranz on December 5, 2016, and was attached to appellees’ motion to enforce the settlement agreement as Exhibit D. The December 5, 2016 “Confidential Settlement Agreement and Full Release” is the first document that details any of the terms of the settlement agreement. Appellants did not sign the December 5, 2016 “Confidential Settlement Agreement and Full Release.”

{¶ 7} Also attached to appellees’ motion to enforce the settlement agreement were several email chains discussing appellants’ unwillingness to sign the “Confidential Settlement Agreement and Full Release.” On January 12, 2017, Zoll & Kranz advised appellees that appellants had raised an issue with the portion of the “Confidential Settlement Agreement and Full Release” language pertaining to Medicare. On January 27, 2017, Zoll & Kranz provided appellees with proposed edits to the release which removed the Medicare provisions, but specifically noted “We do not have client consent but we at least wanted to give you a draft to consider.” A further email from Zoll & Kranz on that date reiterated “But please bear in mind I have not yet been able to get the client on board. Very difficult situation, even though he previously had agreed in writing.” On January 30, 2017, Zoll & Kranz contacted appellees to inquire on their response to the proposed changes to the Medicare provisions, but again noted, “We do not yet have client consent yet * * * * We hope that if the client accepts, we can quickly get the final agreement to him for signature.” Appellees responded that they agreed to the proposed edits, but to “keep [them] posted.” On February 3, 2017, Zoll and Kranz advised appellees that they were sending the finalized release to appellants. The February 3, 2017 “Confidential Settlement Agreement and Full Release” was attached to appellees’ motion to enforce the settlement agreement as Exhibit H. Appellants have at all times refused to sign either the December 5, 2016, or the February 3, 2017 “Confidential Settlement Agreement and Full Release.” On March 2, 2017, Zoll & Kranz moved to withdraw as counsel.

Free access — add to your briefcase to read the full text and ask questions with AI

Aceste v. Stryker Corp., 2020 Ohio 4938 (Ohio Ct. App. 2020).

2020 Ohio 4938 (Aceste v. Stryker Corp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Tackett v. Gunnels
2023 Ohio 3611 (Ohio Court of Appeals, 2023)
Gouveia v. Cvengros
2023 Ohio 1325 (Ohio Court of Appeals, 2023)
Moton v. Schafer
2022 Ohio 3505 (Ohio Court of Appeals, 2022)
Snay v. Burr (Slip Opinion)
2021 Ohio 4113 (Ohio Supreme Court, 2021)